INS and gestational diabetes: Using microarray profiling, GDM (all insulin therapy) preferentially activated genes related to lipid metabolism, with a two-fold up-regulation of FABP4 and FABP5 compared to control, however, LPL expression was down-regulated nearly three-fold [94].